HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
48 hedge funds and large institutions have $37M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $67M → $37M (-$30M)
Holders
48
Holding in Top 10
1
Calls
$30K
Puts
$2K
Top Buyers
| 1 | +$5.44M | |
| 2 | +$1.24M | |
| 3 | +$509K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$348K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$216K |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$1.09M | |
| 3 | -$1.04M | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.01M |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.01M |